ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753577 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753577; 2) Community: the network communities that were significantly associated with the response to NSC 753577; 3) Molecule: the relationships between components within communities and NSC 753577; 4) MDR: the compounds that were significantly associated with the NSC 753577.

NSC Compound Enrichment Correlation
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.0131480612430041 0.16421509
NSC 759228 IDEBENONE 0.0152653588725063 0.15530234
NSC 9706 Triethylenemelamine 0.0152653588725063 0.15849466
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0152653588725064 -0.021842801
NSC 264137 Celiptium 0.0152653588725064 0.11790798
NSC 348401 4-(6-Thioguanine)-7-nitro-2,1,3-benzoxadiazole 0.0152653588725064 0.25195829
NSC 605607 Null 0.0152653588725064 0.048805668
NSC 634368 Chlorobis(4-ethyltropolonato)bismuth(III) 0.0152653588725064 0.081998107
NSC 648365 Insulin-Methotrexate conjugate 0.0152653588725064 0.37228872
NSC 656576 Midostaurin 0.0152653588725064 0.12452114
Total:37  Current:7    [First] [Prev] [Next] [Last]